MEOLA, GIOVANNI
 Distribuzione geografica
Continente #
EU - Europa 13.580
NA - Nord America 11.154
AS - Asia 3.700
SA - Sud America 281
OC - Oceania 69
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 6
Totale 28.833
Nazione #
US - Stati Uniti d'America 10.735
GB - Regno Unito 4.990
IT - Italia 2.933
CN - Cina 1.739
DE - Germania 1.388
SE - Svezia 1.077
UA - Ucraina 555
TR - Turchia 511
FR - Francia 482
IE - Irlanda 455
KR - Corea 437
IN - India 393
CA - Canada 370
NL - Olanda 330
FI - Finlandia 307
EU - Europa 304
RU - Federazione Russa 281
CO - Colombia 165
BE - Belgio 162
JP - Giappone 161
ES - Italia 133
HK - Hong Kong 120
GR - Grecia 96
VN - Vietnam 86
PL - Polonia 78
ID - Indonesia 69
BR - Brasile 66
AU - Australia 58
CH - Svizzera 57
DK - Danimarca 49
CZ - Repubblica Ceca 42
MX - Messico 40
RO - Romania 38
SG - Singapore 37
PT - Portogallo 35
TW - Taiwan 33
PH - Filippine 26
NO - Norvegia 23
EG - Egitto 21
MY - Malesia 21
HU - Ungheria 17
CL - Cile 15
RS - Serbia 15
AR - Argentina 14
IR - Iran 14
IL - Israele 12
BG - Bulgaria 10
NZ - Nuova Zelanda 10
IQ - Iraq 9
HR - Croazia 7
PE - Perù 7
BJ - Benin 6
UZ - Uzbekistan 6
BD - Bangladesh 5
CR - Costa Rica 5
SI - Slovenia 5
TH - Thailandia 5
VE - Venezuela 5
AT - Austria 4
DZ - Algeria 4
EC - Ecuador 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
LT - Lituania 3
PY - Paraguay 3
A1 - Anonimo 2
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CY - Cipro 2
KZ - Kazakistan 2
QA - Qatar 2
SC - Seychelles 2
TN - Tunisia 2
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GH - Ghana 1
GM - Gambi 1
HN - Honduras 1
KW - Kuwait 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
OM - Oman 1
PG - Papua Nuova Guinea 1
PK - Pakistan 1
RE - Reunion 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 29.136
Città #
Southend 4.474
Chandler 1.120
Seattle 967
Milan 734
Fairfield 662
Princeton 656
Wilmington 613
Beijing 456
Dublin 443
Ashburn 436
Woodbridge 395
Jacksonville 394
Dearborn 378
Mountain View 326
Ann Arbor 317
Redmond 307
Houston 304
Cambridge 263
Nanjing 243
Redwood City 225
Somerville 223
Serra 203
Toronto 198
Sakarya 190
Frankfurt am Main 185
Des Moines 162
Bengaluru 161
Andover 158
Bogotá 154
Boardman 147
Rome 140
Brussels 119
Pisa 106
Hamburg 94
Hong Kong 90
Athens 88
Jinan 86
Shenyang 86
Nanchang 79
Berlin 75
Phoenix 73
Sunnyvale 68
New York 67
Shanghai 63
Guangzhou 60
London 60
Medford 60
Helsinki 56
Ottawa 56
Warsaw 56
Hanover 54
Hebei 53
Changsha 50
San Diego 48
Vigo 47
Grafing 46
Tokyo 43
Bitonto 42
Turin 40
Falls Church 38
Tianjin 38
Dong Ket 37
Odernheim 35
Seoul 34
Jiaxing 33
Norwalk 33
Los Angeles 32
Duncan 31
Silver Spring 30
Bologna 29
Chicago 29
Taipei 26
Kunming 25
Kiez 24
Hangzhou 23
Hefei 23
Roxbury 23
Cornate D'adda 22
Ningbo 22
Rochester 22
Cologno Al Serio 21
Salt Lake City 21
Verona 21
Changchun 20
Lanzhou 20
Nijmegen 20
Zhengzhou 20
Como 19
Liberty 18
Taizhou 18
Philadelphia 17
Tappahannock 17
Boston 16
Geisenheim 16
Pune 16
Zurich 16
Florence 15
Fremont 15
Madrid 15
Munich 15
Totale 18.464
Nome #
The progression of Muscular Impairment Rating Scale (MIRS) and the development of cardiac conduction abnormalities in DM1 537
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2 442
Cerebral involvement in myotonic dystrophies 405
Atipica presentazione di sclerosi multipla alla RMN : un caso di difficile diagnosi differenziale 404
Electromechanical delay components during skeletal muscle contraction and relaxation in patients with myotonic dystrophy type 1 400
Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2 368
DM1, DM2 e paralisi periodiche : diagnosi e terapia 340
La canalopatia del cloro : diagnosi clinica differenziale 326
Andersen's syndrome : a distinct periodic paralysis 324
Cognitive impairment in adult myotonic dystrophies : a longitudinal study 310
The analysis of myotonia congenita mutations discloses functional clusters of amino acids within the CBS2 domain and the C-terminal peptide of the ClC-1 channel 310
Increased visceral adipose tissue rather than BMI as a risk factor for dementia 293
Treatment for periodic paralysis 284
Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy 239
Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion 235
Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency 227
A newly-described myotonic disorder (proximal myotonic myopathy--PROMM): personal experience and review of the literature 225
Tolerability and safety of mexiletine in patients with myotonia dystrophy type 1 over time 222
Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy 205
Deregulated MicroRNAs in Myotonic Dystrophy Type 2 202
Overexpression of CUGBP1 in Skeletal Muscle from Adult Classic Myotonic Dystrophy Type 1 but Not from Myotonic Dystrophy Type 2 201
Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 200
Concurrence of facioscapulohumeral muscular dystrophy and myasthenia gravis 199
Therapy in myotonic disorders and in muscle channelopathies 196
Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2 193
Long-term follow-up free of ventricular fibrillation recurrence after resuscitated cardiac arrest in a myotonic dystrophy type 1 patient 185
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases 180
A family with an unusual myotonic and myopathic phenotype and no CTG expansion (proximal myotonic myopathy syndrome): a challenge for future molecular studies 175
Oculopharyngeal muscular dystrophy in Italy. 172
"I know that you know that I know" : Neural substrates associated with social cognition deficits in DM1 patients 172
Mutation in the S4 segment of the adult skeletal sodium channel gene in an Italian paramyotonia congenita (PC) family 171
Persistent autobiographical amnesia: a case report 169
Studio longitudinale del coinvolgimento muscolare e cardiaco nella Distrofia Miotonica di tipo 1 (DM1) e di tipo 2 (DM2) 168
Amyotrophic lateral sclerosis presenting during pregnancy : report of clinical and genetic features of three cases 168
Status update and interim results from the Asymptomatic Carotid Surgery Trial-2 (ACST-2) 168
Neuropsychological and psychological functioning aspects in myotonic dystrophy type 1 patients in Italy 165
Premature senescence in primary muscle cultures of myotonic dystrophy type 2 is not associated with p16 induction 162
Proteome profile in Myotonic Dystrophy type 2 myotubes reveals dysfunction in protein processing and mitochondrial pathways 161
Electromechanical delay components during skeletal muscle contraction and relaxation : novel physiological insights and possible application in Myotonic Dystrophies 161
Clinical factors associated with statins prescription in acute ischemic stroke patients : findings from the Lombardia Stroke Registry 161
Gonadal failure is associated with visceral adiposity in myotonic dystrophies 158
Alterazioni proteine tau liquorali e quoziente intellettivo (QI) nelle Distrofie Miotonichew di tipo 1 (DM1) e di tipo 2 (DM2). 157
Endocrine alterations in myotonic dystrophy type 1 and type 2 : correlation with markers of muscle fiber atrophy 154
Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle 152
RNA transcription and maturation in skeletal muscle cells are similarly impaired in myotonic dystrophy and sarcopenia : the ultrastructural evidence 151
Tibialis anterior muscle needle biopsy and sensitive biomolecular methods : a useful tool in myotonic dystrophy type 1 151
Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect 149
Migraine and patent foramen ovale: improvement after transcatheteral closure 146
Quantitative myotonia assessment: an experimental protocol 144
Randomized, placebo-controlled trials of dichlorphenamide in periodic paralysis 144
Bimodal administration of entacapone in Parkinson's disease patients improves motor control 142
A CASE OF MITOCHONDRIAL MYOPATHY, LACTIC-ACIDOSIS AND COMPLEX-I DEFICIENCY 142
Myotonia congenita : novel mutations in CLCN1 gene and functional characterizations in Italian patients 141
Abnormalities of proliferative and differentiative properties in DM1 and DM2 senescence myoblasts -in vitro- 138
Myotonia permanens with neonatal onset associated with a p.Gly1306Glu mutation in the SCN4A gene. 137
Pathogenic role of ribonuclear inclusions in myotonic dystrophy type 2: myth or reality? 136
Redefining clinical phenotype in a large color of Italian non-dystrophic myotonic patients. 136
Mexiletine Improves Symptoms and Signs of Myotonia in Non-dystrophic Myotonia 135
[Expression of a defect in the respiratory chain in cultured human cells] 131
Miotonie e canalopatie 130
Electrophysiology study protocol of arrhythmias in myotonic dystrophy type 1 and type 2 130
Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2 130
Gene expression analysis in Myotonic Dystrophy : indications for a common molecular pathogenic pathway in DM1 and DM2 129
Unusual diagnostic and management problems in neuromuscular disease : Gitelman Syndrome 129
New mutations in SCN4A and their biophysical properties 129
Stable hybrid myotubes: a new model for studying re-expression of enzymatic activities in vitro 129
Circulating irisn is reduced in male patients with type 1 and type 2 Myotonic Dystrophies 129
Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism 127
Eight novel mutations in SPG4 gene in a large sample of patients with hereditary spastic paraplegia 126
Lezioni di Traumatologia 125
A multidisciplinary approach improves quality of life perception in patients with amyotrophic lateral sclerosis 125
Cerebrospinal fluid (CSF) tau and amyloid beta42 (A beta 42) protein abnormalities correlate with executive dysfunction in myotonic dystrophy type 1 (DM1) and type 2 (DM2) 124
Computerized tomography and magnetic resonance muscle imaging in Miyoshi's myopathy 124
Reduction of toxic RNAs in myotonic dystrophies type 1 and type 2 by the RNA helicase p68/DDX5 123
Complex IV change in the mitochondria respiratory chain of chronic external ophtalmoplegia : a review of our cases 122
Advanced microscopic and histochemical techniques : diagnostic tools in the molecular era of myology 120
RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1 120
Myotonic dystrophies : state of the art of new therapeutic developments for the CNS 120
Muscle biopsy and cell cultures: potential diagnostic tools in hereditary skeletal muscle channelopathies 119
High-sensitive cardiac troponin T (hs-cTnT) assay as serum biomarker to predict cardiac risk in myotonic dystrophy : A case-control study 119
Acetazolamide prevents vacuolar myopathy in skeletal muascle of K+ -depleted rats 117
Studi di proteomica funzionale in miotubi di pazienti affetti da Distrofia Miotonica di tipo 2 evidenziano alterazioni nelle proteine mitocondriali e nelle proteine coinvolte nel processo di degradazione proteica 117
Human skeletal muscle sodium channelopathies 116
Long-term effects of mexiletine on myotonia and on the cardiac conduction system of patients with myotonic dystrophy type 1 116
Muscle surface mechanical and electrical activities in myotonic dystrophy 116
Manifesting carrier of x-linked Duchenne muscular dystrophy 116
Apoptosis induced by proteasome inhibition in human myoblast cultures 114
A clinical, genetic and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia 113
Development and validation of a new molecular diagnostic assay for detection of myotonic dystrophy type 2 113
Muscleblind-like protein 1 nuclear sequestration and splicing pattern in myotonic dystrophy type 2 112
Ribonuclear inclusions and MBNL1 nuclear sequestration do not affect myoblast differentiation but alter gene splicing in myotonic dystrophy type 2 112
La qualità di vita nelle canalopatie scheletriche: miopatie benigne? 111
Proteomic analysis of DM2 human myotubes reveals alteration in mitochondrial components, in the unfolded protein response and the ubiquitin proteosome system 111
Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1(DM-1) and in proximal myotonic myopathy (PROMM/DM-2) 110
Dysregulation of MicroRNA Expression in Myotonic Dystrophies 110
Plasma microRNAs as biomarkers for myotonic dystrophy type 1 110
Outcome measures and prognostic indicators in patients with amyotrophic lateral sclerosis 109
Dysregulated expression of micrornas in myotonic dystrophy type 1 109
Colocalization of ribonuclear inclusions and MBNL1 foci with no impairment of muscle differentiation in DM2 108
Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies 108
Totale 17.446
Categoria #
all - tutte 62.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.917


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.055 0 0 0 0 0 0 0 0 264 222 248 321
2019/20204.038 452 191 187 332 304 513 491 264 502 496 175 131
2020/20213.654 126 281 254 175 376 264 363 221 344 202 814 234
2021/20223.278 268 126 211 121 238 283 293 135 312 371 276 644
2022/20234.006 568 331 369 463 463 697 148 255 375 78 158 101
2023/20241.684 113 208 155 136 586 177 85 150 74 0 0 0
Totale 30.853